Clinical trial

IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn

NCT01360671

Study summary

ClinicalTrials.gov

IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Sildenafil Normalized identity: sildenafil View linked drug · Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2012-03-01

PhasePHASE2

Conditions

Persistent Pulmonary Hypertension of the Newbornverified · MONDO: persistent fetal circulation syndrome

Interventions

SildenafilDRUG · verified · RxNorm: sildenafil

Sponsors & collaborators

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01360671 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.